secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2022-08-05T23:59:59+00:00
Accession:  0001214659-22-009675
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro CFO Lien Escalona resigns; COO David Katzoff appointed as new CFO
--------------------------------------------------------------------------------

- Lien Escalona resigned as CFO effective August 1, 2022.
- David J. Katzoff, previously COO, appointed CFO on August 5, 2022.
- Katzoff joined Alzamend in Nov 2019 as SVP Operations, then COO from Dec 2020.
- Katzoff also serves as SVP Finance of BitNile Holdings and CFO of Imperalis Holding Corp.
- No employment agreement or compensation change for Katzoff at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/0001214659-22-009675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/e842248k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-22-009675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer